Clinical Trial Update: Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 trial from Zhejiang University is recruiting to assess the efficacy and safety of intravenous YOLT-201 for transthyretin amyloidosis cardiomy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloidosis Cardiomyopathy

Drugs mentioned

• YOLT-201

Snippet

Sponsor: Zhejiang University | Conditions: Transthyroxin Amyloidosis Cardiomyopathy | EARLY_Phase 1 | Status: RECRUITING